Ruzette Antoine A, Kozlova Nina, Cruz Kayla A, Muranen Taru, Nørrelykke Simon F
Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
Department of Genetics, Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
bioRxiv. 2025 May 1:2025.04.28.650414. doi: 10.1101/2025.04.28.650414.
Aggressive cancers, such as pancreatic ductal adenocarcinoma (PDAC), are often characterized by a complex and desmoplastic tumor microenvironment rich in stroma, a supportive connective tissue composed primarily of extracellular matrix (ECM) and non-cancerous cells. Desmoplasia, which is a dense deposition of stroma, is a major reason for therapy resistance, acting both as a physical barrier that interferes with drug penetration and as a supportive niche that protects cancer cells through diverse mechanisms. A precise understanding of spatial cell interactions within the tumor microenvironment in stroma-rich cancers is essential for optimizing therapeutic responses. It allows detailed mapping of stromal-tumor interfaces, comprehensive phenotyping of diverse cell types and their functional states, and insights into changes in cellular distribution and tissue architecture, thus leading to an improved assessment of drug responses. Recent advances in multiplexed immunofluorescence imaging have enabled the acquisition of large batches of whole-slide tumor images, but scalable and reproducible methods to analyze the spatial distribution of cell states relative to stromal regions remain limited. To address this gap, we developed an open-source computational pipeline that integrates QuPath (Bankhead et al. 2017), StarDist (Schmidt et al. 2018), and custom Python scripts to quantify biomarker expression at a single- and sub-cellular resolution across entire tumor sections. Our workflow includes: (i) automated nuclei segmentation using StarDist, (ii) machine learning-based cell classification using multiplexed marker expression, (iii) modeling of stromal regions based on fibronectin staining, (iv) sensitivity analyses on classification thresholds to ensure robustness across heterogeneous datasets, and (v) distance-based quantification of the proximity of each cell to the stromal border. To improve consistency across slides with variable staining intensities, we introduce a statistical strategy that translates classification thresholds by propagating a chosen reference percentile across the distribution of marker-related cell measurement in each image. We apply this approach to quantify spatial patterns of distribution of the phosphorylated form of the N-Myc downregulated gene 1 (NDRG1), a novel DNA repair protein that conveys signals from the ECM to the nucleus to maintain replication fork homeostasis, and a known cell proliferation marker Ki67 in fibronectin-defined stromal regions in PDAC xenografts. The pipeline is applicable for the analysis of various stroma-rich tissues and is publicly available: https://github.com/HMS-IAC/stroma-spatial-analysis-web.
侵袭性癌症,如胰腺导管腺癌(PDAC),通常具有复杂且富含基质的促结缔组织增生性肿瘤微环境,基质是一种主要由细胞外基质(ECM)和非癌细胞组成的支持性结缔组织。促结缔组织增生是基质的致密沉积,是治疗耐药的主要原因,它既作为干扰药物渗透的物理屏障,又作为通过多种机制保护癌细胞的支持性微环境。精确了解富含基质的癌症中肿瘤微环境内的空间细胞相互作用对于优化治疗反应至关重要。它允许对基质 - 肿瘤界面进行详细映射,对不同细胞类型及其功能状态进行全面表型分析,并深入了解细胞分布和组织结构的变化,从而改善对药物反应的评估。多重免疫荧光成像的最新进展使得能够获取大量全切片肿瘤图像,但用于分析相对于基质区域的细胞状态空间分布的可扩展且可重复的方法仍然有限。为了弥补这一差距,我们开发了一个开源计算管道,该管道整合了QuPath(Bankhead等人,2017年)、StarDist(Schmidt等人,2018年)和自定义Python脚本,以在整个肿瘤切片上以单细胞和亚细胞分辨率量化生物标志物表达。我们的工作流程包括:(i)使用StarDist进行自动细胞核分割,(ii)使用多重标记表达进行基于机器学习的细胞分类,(iii)基于纤连蛋白染色对基质区域进行建模,(iv)对分类阈值进行敏感性分析以确保在异质数据集中的稳健性,以及(v)基于距离对每个细胞与基质边界的接近程度进行量化。为了提高具有可变染色强度的玻片之间的一致性,我们引入了一种统计策略,通过在每个图像中标记相关细胞测量值的分布上传播选定的参考百分位数来转换分类阈值。我们应用这种方法来量化N - Myc下调基因1(NDRG1)磷酸化形式的空间分布模式,NDRG1是一种新型DNA修复蛋白,它将信号从ECM传递到细胞核以维持复制叉稳态,以及在PDAC异种移植中纤连蛋白定义的基质区域中的已知细胞增殖标志物Ki67。该管道适用于各种富含基质组织的分析,并且可公开获取:https://github.com/HMS - IAC/stroma - spatial - analysis - web。